Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Assets (2018 - 2025)

Historic Assets for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $764.0 million.

  • Bicycle Therapeutics' Assets fell 2335.52% to $764.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $764.0 million, marking a year-over-year decrease of 2335.52%. This contributed to the annual value of $956.9 million for FY2024, which is 6072.52% up from last year.
  • As of Q3 2025, Bicycle Therapeutics' Assets stood at $764.0 million, which was down 2335.52% from $832.2 million recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Assets ranged from a high of $1.1 billion in Q2 2024 and a low of $223.8 million during Q1 2021
  • Moreover, its 5-year median value for Assets was $479.8 million (2021), whereas its average is $584.2 million.
  • Its Assets has fluctuated over the past 5 years, first skyrocketed by 19772.64% in 2021, then crashed by 2335.52% in 2025.
  • Over the past 5 years, Bicycle Therapeutics' Assets (Quarter) stood at $479.8 million in 2021, then decreased by 14.42% to $410.6 million in 2022, then surged by 44.99% to $595.3 million in 2023, then skyrocketed by 60.73% to $956.9 million in 2024, then fell by 20.16% to $764.0 million in 2025.
  • Its Assets was $764.0 million in Q3 2025, compared to $832.2 million in Q2 2025 and $883.9 million in Q1 2025.